LMRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lumexa Imaging Holdings Inc (LMRI) is a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 to invest. The stock has strong analyst support, favorable growth prospects, and a solid market position, despite the lack of immediate trading signals. The recent price dip could present a buying opportunity for long-term gains.
The MACD is positive and contracting, indicating a potential weakening upward momentum. RSI is neutral at 50.576, suggesting no overbought or oversold conditions. Moving averages are converging, showing no clear trend direction. Key support is at 12.965, and resistance is at 16.074, with the current price of 14.57 near the pivot point of 14.52.
Strong analyst ratings with multiple buy and outperform ratings and price targets ranging from $22 to $
Favorable growth drivers, including increasing demand for diagnostic imaging, new center openings, and a growing advanced imaging mix.
Recent Raymond James upgrade to Strong Buy, citing valuation and growth strategy.
Positive earnings surprise in the latest quarter.
Regular market price decline of -1.84% and a slight pre-market decline of -0.82%.
Neutral trading sentiment from hedge funds and insiders.
Financials show a net loss of -$25.058 million and negative EPS of -0.19, though improving.
In Q4 2024, revenue was $248.028 million, showing no YoY growth. Net income improved but remained negative at -$25.058 million. EPS also improved but stayed negative at -0.19. Gross margin increased to 11.58%.
Analysts are highly positive on LMRI, with multiple firms initiating coverage with Buy or Overweight ratings and price targets of $22-$23. Analysts highlight strong local market positions, secular growth drivers, and a favorable shift toward outpatient care. Raymond James recently upgraded the stock to Strong Buy, citing valuation and growth strategy.
